AAPL   319.34 (+0.14%)
MSFT   183.03 (-0.26%)
FB   236.09 (+0.50%)
GOOGL   1,433.18 (+1.41%)
AMZN   2,437.19 (+0.01%)
NVDA   352.31 (-2.42%)
CGC   20.18 (+3.86%)
BABA   203.34 (+1.82%)
GE   6.88 (+7.17%)
TSLA   825.40 (+1.04%)
AMD   54.19 (-1.78%)
T   31.01 (+3.78%)
ACB   15.75 (-1.62%)
F   5.86 (+3.72%)
GILD   74.05 (+0.95%)
DIS   121.68 (+3.10%)
NFLX   416.73 (-2.93%)
BAC   24.38 (+7.59%)
BA   145.25 (+5.61%)
AAPL   319.34 (+0.14%)
MSFT   183.03 (-0.26%)
FB   236.09 (+0.50%)
GOOGL   1,433.18 (+1.41%)
AMZN   2,437.19 (+0.01%)
NVDA   352.31 (-2.42%)
CGC   20.18 (+3.86%)
BABA   203.34 (+1.82%)
GE   6.88 (+7.17%)
TSLA   825.40 (+1.04%)
AMD   54.19 (-1.78%)
T   31.01 (+3.78%)
ACB   15.75 (-1.62%)
F   5.86 (+3.72%)
GILD   74.05 (+0.95%)
DIS   121.68 (+3.10%)
NFLX   416.73 (-2.93%)
BAC   24.38 (+7.59%)
BA   145.25 (+5.61%)
AAPL   319.34 (+0.14%)
MSFT   183.03 (-0.26%)
FB   236.09 (+0.50%)
GOOGL   1,433.18 (+1.41%)
AMZN   2,437.19 (+0.01%)
NVDA   352.31 (-2.42%)
CGC   20.18 (+3.86%)
BABA   203.34 (+1.82%)
GE   6.88 (+7.17%)
TSLA   825.40 (+1.04%)
AMD   54.19 (-1.78%)
T   31.01 (+3.78%)
ACB   15.75 (-1.62%)
F   5.86 (+3.72%)
GILD   74.05 (+0.95%)
DIS   121.68 (+3.10%)
NFLX   416.73 (-2.93%)
BAC   24.38 (+7.59%)
BA   145.25 (+5.61%)
AAPL   319.34 (+0.14%)
MSFT   183.03 (-0.26%)
FB   236.09 (+0.50%)
GOOGL   1,433.18 (+1.41%)
AMZN   2,437.19 (+0.01%)
NVDA   352.31 (-2.42%)
CGC   20.18 (+3.86%)
BABA   203.34 (+1.82%)
GE   6.88 (+7.17%)
TSLA   825.40 (+1.04%)
AMD   54.19 (-1.78%)
T   31.01 (+3.78%)
ACB   15.75 (-1.62%)
F   5.86 (+3.72%)
GILD   74.05 (+0.95%)
DIS   121.68 (+3.10%)
NFLX   416.73 (-2.93%)
BAC   24.38 (+7.59%)
BA   145.25 (+5.61%)
Log in

NASDAQ:CTRECaretrust REIT Stock Price, Forecast & News

$19.41
+0.59 (+3.13 %)
(As of 05/26/2020 01:14 PM ET)
Add
Compare
Today's Range
$19.19
Now: $19.41
$19.95
50-Day Range
$13.04
MA: $16.73
$18.82
52-Week Range
$7.16
Now: $19.41
$25.52
Volume35,133 shs
Average Volume690,737 shs
Market Capitalization$1.86 billion
P/E Ratio37.33
Dividend Yield5.31%
Beta1.01
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition and leasing of seniors housing and healthcare-related properties. With 199 net-leased healthcare properties and three operated seniors housing properties in 27 states, CareTrust is pursuing opportunities across the nation to acquire properties that will be leased to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses.
Read More
Caretrust REIT logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.3Community Rank: 2.6Dividend Strength: 3.3Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.37 out of 5 stars


Industry, Sector and Symbol

Industry Real estate investment trusts
Sub-IndustryN/A
SectorFinance
Current SymbolNASDAQ:CTRE
Previous SymbolNASDAQ:CTREV
CUSIPN/A
Phone949-542-3130

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$163.40 million
Cash Flow$1.13 per share
Book Value$9.71 per share

Profitability

Net Income$46.36 million

Miscellaneous

Employees57
Market Cap$1.86 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive CTRE News and Ratings via Email

Sign-up to receive the latest news and ratings for CTRE and its competitors with MarketBeat's FREE daily newsletter.

Caretrust REIT (NASDAQ:CTRE) Frequently Asked Questions

How has Caretrust REIT's stock been impacted by COVID-19 (Coronavirus)?

Caretrust REIT's stock was trading at $16.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CTRE shares have increased by 14.2% and is now trading at $19.41. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Caretrust REIT?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Caretrust REIT in the last year. There are currently 3 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Caretrust REIT.

When is Caretrust REIT's next earnings date?

Caretrust REIT is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Caretrust REIT.

How were Caretrust REIT's earnings last quarter?

Caretrust REIT Inc (NASDAQ:CTRE) issued its quarterly earnings results on Thursday, May, 7th. The real estate investment trust reported $0.20 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.34 by $0.14. The real estate investment trust had revenue of $44.34 million for the quarter, compared to the consensus estimate of $43.20 million. Caretrust REIT had a return on equity of 5.32% and a net margin of 29.53%. View Caretrust REIT's earnings history.

How often does Caretrust REIT pay dividends? What is the dividend yield for Caretrust REIT?

Caretrust REIT declared a quarterly dividend on Friday, March 13th. Shareholders of record on Tuesday, March 31st will be paid a dividend of $0.25 per share on Wednesday, April 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 5.15%. The ex-dividend date is Monday, March 30th. This is a boost from Caretrust REIT's previous quarterly dividend of $0.23. View Caretrust REIT's dividend history.

What guidance has Caretrust REIT issued on next quarter's earnings?

Caretrust REIT issued an update on its FY 2020 After-Hours earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of 1.32-1.34 for the period.

What price target have analysts set for CTRE?

7 Wall Street analysts have issued 12 month target prices for Caretrust REIT's stock. Their forecasts range from $13.00 to $26.00. On average, they anticipate Caretrust REIT's stock price to reach $21.29 in the next twelve months. This suggests a possible upside of 9.7% from the stock's current price. View analysts' price targets for Caretrust REIT.

Has Caretrust REIT been receiving favorable news coverage?

News coverage about CTRE stock has trended positive on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Caretrust REIT earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave news stories about the real estate investment trust a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutCaretrust REIT.

Are investors shorting Caretrust REIT?

Caretrust REIT saw a drop in short interest in the month of May. As of May 15th, there was short interest totaling 1,790,000 shares, a drop of 15.6% from the April 30th total of 2,120,000 shares. Based on an average trading volume of 999,900 shares, the days-to-cover ratio is presently 1.8 days. Currently, 1.9% of the shares of the stock are sold short. View Caretrust REIT's Current Options Chain.

Who are some of Caretrust REIT's key competitors?

What other stocks do shareholders of Caretrust REIT own?

Who are Caretrust REIT's key executives?

Caretrust REIT's management team includes the following people:
  • Mr. Gregory K. Stapley J.D., Chairman, Pres & CEO (Age 59)
  • Mr. William M. Wagner, CFO, Treasurer & Sec. (Age 53)
  • Mr. David M. Sedgwick, Chief Operating Officer (Age 43)
  • Mr. Mark D. Lamb, Chief Investment Officer
  • Ms. Lauren Beale, Controller

What is Caretrust REIT's stock symbol?

Caretrust REIT trades on the NASDAQ under the ticker symbol "CTRE."

Who are Caretrust REIT's major shareholders?

Caretrust REIT's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (18.94%), PGGM Investments (9.32%), State Street Corp (4.37%), Invesco Ltd. (3.96%), Bank of New York Mellon Corp (3.19%) and Geode Capital Management LLC (1.50%). View institutional ownership trends for Caretrust REIT.

Which major investors are selling Caretrust REIT stock?

CTRE stock was sold by a variety of institutional investors in the last quarter, including Centersquare Investment Management LLC, Morgan Stanley, BlackRock Inc., Bank of New York Mellon Corp, Baird Financial Group Inc., Victory Capital Management Inc., Victory Capital Management Inc., and Westpac Banking Corp. View insider buying and selling activity for Caretrust REIT.

Which major investors are buying Caretrust REIT stock?

CTRE stock was purchased by a variety of institutional investors in the last quarter, including PGGM Investments, Cohen & Steers Inc., State Street Corp, Employees Retirement System of Texas, Invesco Ltd., Two Sigma Advisers LP, Nuveen Asset Management LLC, and Geode Capital Management LLC. View insider buying and selling activity for Caretrust REIT.

How do I buy shares of Caretrust REIT?

Shares of CTRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Caretrust REIT's stock price today?

One share of CTRE stock can currently be purchased for approximately $19.41.

How big of a company is Caretrust REIT?

Caretrust REIT has a market capitalization of $1.86 billion and generates $163.40 million in revenue each year. The real estate investment trust earns $46.36 million in net income (profit) each year or $1.36 on an earnings per share basis. Caretrust REIT employs 57 workers across the globe.

What is Caretrust REIT's official website?

The official website for Caretrust REIT is www.caretrustreit.com.

How can I contact Caretrust REIT?

Caretrust REIT's mailing address is 905 CALLE AMANECER SUITE 300, SAN CLEMENTE CA, 92673. The real estate investment trust can be reached via phone at 949-542-3130 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.